
Renafor-B200 mcg+6
Renata Limited
Budesonide + Formoterol Fumarate is a fixed-dose combination inhaler containing an inhaled corticosteroid (budesonide) and a long-acting beta2-agonist (formoterol fumarate) and more.
Budesonide + Formoterol Fumarate is a fixed-dose combination inhaler containing an inhaled corticosteroid (budesonide) and a long-acting beta2-agonist (formoterol fumarate), indicated for the following:
Budesonide + Formoterol Fumarate is administered by oral inhalation only, on a regular scheduled basis (not as needed). The lowest strength that effectively controls symptoms should be used, and the dose should be individualized by the treating physician.
| Indication | Typical Adult Dosing | Notes |
|---|---|---|
| Asthma maintenance (adults and adolescents) | Usually 2 inhalations twice daily (morning and evening) of the strength prescribed | Some regimens allow once-daily dosing in mild disease; follow physician's instructions |
| COPD maintenance | Usually 2 inhalations twice daily of the higher-strength product | Not for once-daily use in COPD; twice-daily regular dosing |
| Pediatric asthma (where approved, generally 6 years and older) | 2 inhalations twice daily of the lowest appropriate pediatric strength | Use only the strength/device approved for the child's age; see Pediatric Use |
Side effects of Budesonide + Formoterol Fumarate may involve either the inhaled corticosteroid component, the long-acting beta2-agonist component, or both.
Budesonide + Formoterol Fumarate is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.